The aim of this study was to survey general practitioners (GPs) and community pharmacists (CPs) in Ireland regarding current practices of medication management, specifically medication reconciliation, communication between healthcare providers and medication errors as patients transition in care.
Introduction:
Medication discrepancies during transitions of care can occur as a result of incomplete or inaccurate communication as responsibility shifts between healthcare providers or back to the patient. These discrepancies are common, reported in up to 67% of hospital admissions, and have been linked to potential as well as actual adverse drug events (ADEs) 1-3 . The coordination of care, in particular improved systems of transfer of medication information at transitions, especially for those with complex chronic illnesses is essential 4 . Policy recommendations in the area have been numerous, with reports recommending coordinated care delivered by community based multi-professional teams, mandating all healthcare providers deliver medication reconciliation (A 3 step process -verification of a current medication list, clarification of directions and appropriateness; and documentation of changes 5 .); as well as minimum datasets and safe modes of transfer of patient information on referral and discharge. 4, 6, 7 Medication reconciliation has been promoted by many statutory and safety focused organizations and a number of studies have explored the most effective method of medication reconciliation 3, [8] [9] [10] [11] [12] . Most existing studies have been prevalence studies of discrepancies attempting to identify high risk groups and transitions, or trials of pharmacist and Information Technology (IT) mediated interventions with only a few studies investigating primary care based healthcare professionals (HCPs) opinion on their role in reducing and preventing errors at transitions [13] [14] [15] . Barriers to effective reconciliation have been grouped as patient, provider and system factors; in considering designing solutions to reconciliation issues it is necessary to examine these factors more closely 16 .
The aim of this study was to gather information from general practitioners (GPs) and community pharmacists (CPs) on current practices of medication management at the primary/secondary care interface in Ireland. Specific objectives of the study included an assessment of the experience of prescribing errors following transition, identification of medication reconciliation practices, and evaluating the quality of communication/relationship between HCPs.
Methods:
A cross sectional, self-administered electronic questionnaire which facilitates anonymous completion was devised based on the literature and the input of a group of relevant GPs and CPs. The questionnaire had a mix of quantitative response options as well as free text responses. Core content consisted of basic demographics, details on employment and professional experience. In addition, questions on current medication management practices (specifically medication reconciliation), the quality of communication and relationship with other healthcare providers, as well as the experience and handling of prescribing errors were included.
Setting & Population:
Healthcare in the Republic of Ireland is provided through a mixed model of funding. In order to attain a statistically representative sample of the target population, allowing for a 15% response rate, a sample size of 346 for each profession was calculated (margin of error: 5%, confidence level: 95%). Participants were incentivized, with their consent, to complete the survey (voluntary participation in a prize draw for a gift voucher).
Analysis:
One researcher (HC) was primarily responsible for data entry with a second (PR) verifying a random All free text responses were reviewed by the inductive method of data-driven content analysis, developing themes linked to individual participants' contributions.
Results

Quantitative survey results
In total, 949 out of 5057 questionnaires were returned resulting in an overall response rate of 17.7%; the response rate was 20.7% (n=554) and 14.4% (n=343) for GPs and CPs respectively.
Demographic data of respondents are summarised in Table 1 . There was broad representation from all geographic regions, with more male GP respondents (n=317, 57.2%) but more female CP respondents (n=223, 65%).
Respondent characteristics
The majority of GP respondents were GP principals (n=349, 63%) working with other GPs as part of a larger practice (n=407, 73%), with computerised prescribing records (n=517, 96%), seeing [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] individual patients per session/half day (n=430, 78%). A third of CPs (n=119, 35%) held a role as a Supervising Pharmacist, dispensing >3000 prescriptions/month (n=103, 30%); more than half described themselves as employees (n=189, 55%), working in an independently run pharmacy (n=193, 57%).
Views on medication reconciliation
Most GP respondents did not feel they had a formal system for medication reconciliation (n=327, 60%). Nevertheless, three quarters of GPs (n=298, 75.4%) rated the standard of medication reconciliation in their practice as being good to excellent. Most CPs had systems in place to identify omissions (n=213, 74.5%) and newly initiated medications (n=220, 76.9%) in their patients' prescriptions.
Almost all GPs (n=396; 97.8%) agreed or strongly agreed reconciling medication was an important way to both improve medication safety, with both GPs (93%) and CPs (93%) in agreement that it was also an important way to improve medication adherence. Only 22% (n=90) of GPs agreed that reconciliation was best handled by pharmacists. However, the majority (74%) of CPs agreed/strongly agreed that they were best placed to handle reconciliation, with 88% agreeing their time was wellspent updating the patient medication list.
When asked to rank what information they considered most important to include when receiving details of medications from other HCPs, respondents ranked a full list of current medications (GP n=314, 69.6%; CP n=171, 64.5%) followed by details of any change to long-term medication (GP n=76, 16.6%; CP n=33, 12.2%) as most important. Details of previous adverse effects (GP n= 10, 2.2%; CP n=3, 4.1%) and special administration requirements (GP n=10, 3.8%; CP n=11, 3.7%) were considered the least important information. There was no overall difference in the mean rankings given to items selected by GP and CP (p=0.72)
Communication and relationship between GP, CP, hospital pharmacist, public and private hospitals
There were mixed views amongst GPs and CPs regarding communication with their local publicly funded hospital, with approximately a third describing it as poor/very poor and a similar proportion describing it as good to very good. Most GPs did not receive communication electronically about prescriptions from their local hospitals (n=348, 64%). There were differences in satisfaction levels between HSE regions. Respondents in Dublin North East were, on average, 40% less likely, and those in the West 34% less likely, to report higher levels of satisfaction in communication with public hospitals than their counterparts in Dublin Mid-Leinster, [adjusted odds ratio (AOR):0.60, 95%CI: 0.41-0.87, p=0.01; AOR: 0.68, 95%CI: 0.45-0.95, p=0.03 respectively]. These effects did not vary between GPs and CPs (p=0.53). Differences in levels of satisfaction between HSE regions in satisfaction of communication with private hospitals were not apparent. CPs were less likely to rate communication with private hospitals favourably compared to GPs (AOR: 0.66, 95%CI: 0.48-0.90, p=0.01).
The opinion of GPs and CPs on their relationship with each other was generally positive, with 62% (n=311) of GPs and 52.5% (n=150) of CPs describing the relationship as very good ( Table 2) .
Regarding hospital pharmacists (HP), nearly 40% of GPs described the quality of communication as poor/very poor. Adjustment for age, gender, location, hours worked and distance from a public hospital had no significance. Both CPs (86%) and GPs (87%) were in favour of expanding the role for HPs in identifying and preventing prescribing errors as patients experienced care transitions.
Similarly, GPs (74%) and CPs (82%) felt the role of the community pharmacist should be expanded in the identification and prevention of prescribing errors following a transition.
Experience of prescribing errors
Almost 84% (n=320) and 87.2% (n=205) of GPs and CPs respectively reported that they could remember mistakes in patients' prescriptions, which may have been due to poor transfer of information following a care transition (e.g. delayed or no discharge prescription available, omission of long-term medications) in the past six months (p=0.27; Table 3 ). Although in-patient discharge prescriptions were selected by both respondent groups as being the single largest source of prescription error (GP 21.6%, CP 16.8%), all sources of prescriptions including out-patients, emergency departments, in-patient discharges and private hospitals were implicated. There was evidence (p<0.001) of an overall significant difference in the sources of mistakes in prescribing errors identified between GPs and CPs. GP transcription of hospital prescriptions was identified as also being a source of error with 67.7% of CPs stating it was likely/very likely for an error to arise. In general, managing identified errors was recognised as being complicated with most respondents (CP n=170, 79.4%; GPs n=253, 88.1%) finding it difficult or impossible to contact hospital prescribers.
Free text content analysis survey results (Quotes summarised in Table 4):
The examination of free text responses generated four broad categories representing a number of subthemes. An expanded role for CPs was also highlighted by some respondents (II): The clinical guidance given to junior hospital doctors in preparing discharge summaries and prescriptions was also raised as an issue (III):
CPs underlined the role that HPs could play in improving safe and appropriate prescribing by providing an additional layer of review in the transition process for patients (IV). Finally, the fragmented nature of the healthcare system itself was also noted. There were issues regarding the lack of printed or computerised discharge letters/prescriptions, interoperability of hospital/pharmacy and GP software systems, a 'safety net' for some categories of patients, and resources (V-VII):
Relationship and quality of communication between HCPs
A good relationship was reported between the two groups of HCPs by respondents. The strength of this relationship in terms of improving patient safety was highlighted (VIII). The specific skills of the CP were recognised and valued by GPs, even when correcting GP prescribing or seeming to be particularly fastidious (IX).
A significant theme in terms of contributions from respondents was disappointment with the quality of communication within the health system,, particularly when attempting to contact hospital prescribers to resolve identified problems or ambiguities with prescriptions outside of normal working hours (X-XI).
Role of the patient/vulnerable patients
Respondents highlighted the need for involvement of patients in ensuring correct prescribing information was transmitted. Some respondents felt patients contributed to the lack of clarity (XII).
Comments also indicated that patients should be respected and engaged when making changes to their prescriptions (XIII).
Respondents highlighted patients with multi-morbidity and those with mental health issues as having the greatest risk of medication error due to frequent transitions of care and specialist review without a global view of their medications (XIV).
Prescribing errors
The majority or participants recalled that they had seen any errors in their patients' prescriptions over the past six months. There was almost universal agreement, with many examples given of errors (XV-XVI).
Discussion
Internationally, patient safety incidents are relatively common in primary care and prescribing incidents are those most likely to cause avoidable harm to the patient 17 . The main findings of this study highlighted a high level of experience of prescribing errors following transitions, an absence of formalised medication reconciliation practices in GP practices, dissatisfaction with the current standard of communication between primary and secondary care, and support for a greater role for both HPs and CPs in medication management.
Implementing formal systems of medication reconciliation was a key recommendation in terms of medication safety in a Department of Health & Children, Ireland report in 2008 6 . Despite this and the fact that both responding GPs and CPs were positive about the benefits of medication reconciliation in terms of prescribing safety and adherence, formal systems of medication reconciliation were not in place in most GP practices. A greater understanding is needed as to why improvements in medication reconciliation have not been adopted by the majority of GPs.
Our results are in-keeping with barriers and potential solutions identified internationally to medication management at transitions of care 15 . In terms of provider and organisational issues, concerns with poor communication across the primary/secondary interface were highlighted, with many examples of errors arising. While the reason for the reported geographic difference in opinion on the quality of communication is not clear from this study, a discrepancy between regions in terms of the in-patient clinical pharmacy services provided has been recorded previously 18 . Furthermore, there is a deficit in the limited use of IT to improve communication, as well as its possible role in reconciliation. GPs reported having limited contact with CPs and both groups felt HPs could play a greater role in interacting with primary care HCPs. This lack of contact between HPs and community HCPs has been confirmed previously with a majority of hospitals having no arrangement for HPs involvement or communication to primary care based HCPs upon patient discharge 18 .
Conversely the relationship between GPs and CPs was rated positively by the majority of both groups. However, there was a frustration from some CPs that they could not contribute more in the management of medications. Indeed high quality trials of CPs effectiveness in medication management, while limited in number, are generally favourable 11 . Furthermore, 22% of GPs agreed that reconciliation was best handled by pharmacists while 74% of CPs agreed/strongly agreed that they were best placed to handle reconciliation. This highlights a possible ambiguity around 'ownership' of outpatient medications and the difficulty in developing a community of HCPs to coordinate care for patients as recommended in the King's Fund and subsequent commissioner reports in the UK 4, 19 . This is further compounded by the majority of GP respondents' view that CPs role in medication management could be enhanced. This apparent conflict in findings is perhaps representative of the legal underpinning of prescribing authority in Ireland -CPs can contribute to the process, but do not have prescribing authority.
The majority of both groups noted that they were exposed to errors in prescriptions in the past 6 months, following a transition of care. These findings are consistent with international experience, particularly omission of chronic medications and possible subsequent re-hospitalisation and mortality 2, 20 . The fact that respondents also expected more ADEs to occur than is the case is also supported by previous reviews that found that most unintentional discrepancies had no apparent clinical significance 3 .
Respondents also highlighted a lack of funding to dedicate time and staff to reconciliation -an issue likely impacting development of additional services in secondary care too (e.g. HP availability for discharge reconciliation). Finally, a theme which resonates with much of the literature around multimorbidity was the lack of patient involvement in the process of coordinating transitions for complex patients.
Limitations
There are some limitations to the study. Firstly, the response rate (17.7 %), similar to many electronic surveys, was low and the possibility of responder bias needs to be taken into consideration.
Nevertheless, the demographics of GP and CP responders were comparable to data published in two national reports, giving confidence that the respondents comprise a representative sample.
Additionally, many of the findings were consistent with international literature. Secondly, although the questionnaire enabled the collection of data from a large number of respondents, it may have been limited in its ability to gain rich in-depth information on behaviours and feelings. Finally, with self-report questionnaires, the issue of socially desirable responding (i.e. the tendency for participants to present a favourable image of themselves) should be considered.
Conclusion
The findings from this study are consistent with previous research highlighting HCPs' recognition of prescribing errors as being a common event at transitions of care. Poor communication between primary care HCPs and secondary care, as well as the call for a more "structured seamless care programme" linking primary and secondary care, were also highlighted. A suggestion of geographical variation in satisfaction with communication also emerged. The results of this study confirm that while there is enthusiasm for the benefits of medication reconciliation, there are limited formal structures in primary care to support it, despite it being a stated aim of regulatory agencies. Additionally, CPs have limited opportunity to contribute in medication reviews and the role of HPs in coordinating transitions could, in the respondents' view, be expanded. Future research should focus on the barriers identified in this study in implementing medication reconciliation and improving medication management at transitions. Table 1 Characteristics of GP and CP respondents. Table 2 Quality of communication between GP/CP and Primary/Secondary Table 3 Comparison of GPs and CPs experience and handling of prescribing errors. "There needs to be accountability by consultant/senior team member so that scripts and letters written by inexperienced interns and SHOs [Senior House Officers] are reviewed at time of discharge or at the very least post discharge a chart review in a timely fashion. It is impossible to expect a junior doctor to understand the importance of this crucial step unless he/she is taught this by their seniors"
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iv. "Hospital pharmacists have the knowledge and access to current clinical in-patient notes and determine which medications have been adjusted and to communicate this to the team/GP on discharge. The main reason that this is not happening across the country is due to poor resourcing of pharmacists in hospital and inadequate staffing levels so that they do not have time to perform this function in all wards etc. I have worked in hospitals/units before where the pharmacist played a key role in reviewing medication lists on discharge and there is no doubt that this prevented many prescribing/transcribing errors" "…patients can go straight to any pharmacy in any town with a prescription -lots of scope for errors and misunderstandings to occur and in relation to private patients, they may not attend at GP at all and in some cases prescriptions are dispensed by pharmacies without any medical check being done"
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